NCT05546255 2022-09-19
Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown
Clinical Trials
9 trialsNCT05089643 2022-01-10
Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT04452370 2021-07-21
Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT04437160 2020-06-18
Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
ChineseAMS
Phase 2 Recruiting
NCT03876886 2019-03-21
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency
ChineseAMS
Phase 3 Unknown
NCT02595138 2015-11-03
Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer
ChineseAMS
Phase 3 Unknown
NCT01928680 2015-02-23
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01378533 2011-12-28
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
ChineseAMS
Phase 3 Unknown
NCT01276769 2011-11-16
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown